Polyrizon
(NASDAQ) PLRZ
Polyrizon Financials at a Glance
Market Cap
$28.76M
Revenue (TTM)
$0.00
Net Income (TTM)
-$3.34M
EPS (TTM)
-$2.70
P/E Ratio
-5.11
Dividend
$0.00
Beta (Volatility)
-0.78 (Low)
Dividend
$0.00
Beta (Volatility)
-0.78 (Low)
Price
$13.80
Volume
117,271
Open
$12.60
Price
$13.80
Volume
117,271
Open
$12.60
Previous Close
$13.80
Daily Range
$12.52 - $13.83
52-Week Range
$2.88 - $18.20
Estimated Earnings Date
Jul 1, 2026
Dividend
$0.00
Beta (Volatility)
-0.78 (Low)
Price
$13.80
Volume
117,271
Open
$12.60
Previous Close
$13.80
Daily Range
$12.52 - $13.83
52-Week Range
$2.88 - $18.20
Estimated Earnings Date
Jul 1, 2026
PLRZ News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Polyrizon
Industry
Biotechnology
Sector
Health CareEmployees
6
CEO
Tomer Izraeli, MBA
Website
polyrizon-biotech.comHeadquarters
Ra'anana, 4366507, IL
PLRZ Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-16.94%
Return on Capital
-29.77%
Return on Assets
-15.56%
Earnings Yield
-19.57%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$28.76M
Shares Outstanding
2.08M
Volume
117.27K
Avg. Volume
45.77K
Financials (TTM)
Gross Profit
-$342.00K
Operating Income
-$6.25M
EBITDA
-$5.91M
Operating Cash Flow
-$4.06M
Capital Expenditure
-$7.50K
Free Cash Flow
-$4.07M
Cash & ST Invst.
$12.27M
Total Debt
$0.00
Polyrizon Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$153.00K
-30.8%
Gross Margin
0.00%
N/A
Market Cap
$28.76M
N/A
Market Cap/Employee
$14.38M
N/A
Employees
2
N/A
Net Income
-$3.16M
-230.0%
EBITDA
-$3.61M
-330.9%
Quarterly Fundamentals
Total Cash
$12.27M
+380.5%
Total Debt
$0.00
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-15.56%
N/A
Return on Invested Capital
-29.77%
N/A
Free Cash Flow
-$2.71M
-234.8%
Operating Cash Flow
-$2.71M
-234.2%